1.
Tunisie Medicale [La]. 2015; 93 (6): 350-352
Dans Anglais
| IMEMR
| ID: emr-177346
Résumé
Introduction: Sorafenib, an oral multikinase inhibitor, has recently been shown to improve overall survival in patients with advanced hepatocellular carcinoma [HCC] but only a handful of reports of complete remission on sorafenib have been issued
Case report: We report an intriguing case of advanced HCC complicating HCV infection with cirrhosis, in which the patient achieved complete remission by prolonged administration of sorafenib
Conclusion: Identifying factors that could be associated with good response to this therapy are needed